Literature DB >> 9828768

Elevated serum IL-8 levels are associated with disease activity in idiopathic intermediate uveitis.

A M Klok1, L Luyendijk, M J Zaal, A Rothova, C E Hack, A Kijlstra.   

Abstract

AIM: To find a laboratory indicator for systemic involvement in intermediate uveitis.
METHODS: Interleukin 8 (IL-8) and C reactive protein (CRP) serum levels were measured in patients with idiopathic intermediate uveitis (n = 61), uveitis controls (n = 143), and normal controls (n = 29). The records of those with intermediate uveitis were reviewed with the emphasis on disease activity and severity as characterised by the presence of cystoid macular oedema, vitreous exudates or snowbank formation, papillitis, and periphlebitis.
RESULTS: Increased serum IL-8 (> or = 20 pg/ml) was found in 27 out of 61 patients with intermediate uveitis (p < 0.01), 12 of 27 patients with sarcoid uveitis (p < 0.05), in 19 of 30 patients with HLA-B27 associated acute anterior uveitis (p < 0.05), and in five of 29 healthy controls. Raised IL-8 levels in intermediate uveitis were significantly associated with active disease (p < 0.001) and the presence of vitreous exudates (p < 0.001), papillitis, and periphlebitis (p < 0.01). Elevated CRP levels were found in 12 of the 143 uveitis controls but in none of the intermediate uveitis patients or normal controls. During follow up an associated systemic disease was more frequently noticed in patients with an elevated serum IL-8 at entry into the study.
CONCLUSIONS: Elevated IL-8 serum levels were found in patients with active intermediate uveitis of unknown origin. An elevated IL-8 level seems to predispose the patient to a later development of associated systemic disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9828768      PMCID: PMC1722703          DOI: 10.1136/bjo.82.8.871

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  20 in total

Review 1.  Molecular genetics, structure, and function of C-reactive protein.

Authors:  J M Kilpatrick; J E Volanakis
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

Review 2.  A review on the biological properties of C-reactive protein.

Authors:  V Kolb-Bachofen
Journal:  Immunobiology       Date:  1991-09       Impact factor: 3.144

3.  Multiple sclerosis, sarcoidosis and other diseases in patients with pars planitis.

Authors:  M Zierhut; C S Foster
Journal:  Dev Ophthalmol       Date:  1992

4.  International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease.

Authors:  E Bloch-Michel; R B Nussenblatt
Journal:  Am J Ophthalmol       Date:  1987-02-15       Impact factor: 5.258

5.  Interleukin-8 in sepsis: relation to shock and inflammatory mediators.

Authors:  C E Hack; M Hart; R J van Schijndel; A J Eerenberg; J H Nuijens; L G Thijs; L A Aarden
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

Review 6.  Neutrophil attractant/activation protein-1 (NAP-1 [interleukin-8]).

Authors:  E J Leonard; T Yoshimura
Journal:  Am J Respir Cell Mol Biol       Date:  1990-06       Impact factor: 6.914

7.  Neutrophil chemotactic factor (IL-8) gene expression by cytokine-treated retinal pigment epithelial cells.

Authors:  V M Elner; R M Strieter; S G Elner; M Baggiolini; I Lindley; S L Kunkel
Journal:  Am J Pathol       Date:  1990-04       Impact factor: 4.307

8.  Circulating ICAM-1 levels in serum of uveitis patients.

Authors:  E Arocker-Mettinger; L Steurer-Georgiew; M Steurer; V Huber-Spitzy; E Hoelzl; G Grabner; A Kuchar
Journal:  Curr Eye Res       Date:  1992       Impact factor: 2.424

9.  Pars planitis.

Authors:  D E Henderly; A J Genstler; N A Rao; R E Smith
Journal:  Trans Ophthalmol Soc U K       Date:  1986

10.  Enhanced synthesis of neutrophil-activating peptide-1/interleukin-8 in active ulcerative colitis.

Authors:  Y R Mahida; M Ceska; F Effenberger; L Kurlak; I Lindley; C J Hawkey
Journal:  Clin Sci (Lond)       Date:  1992-03       Impact factor: 6.124

View more
  13 in total

1.  Soluble ICAM-1 serum levels in patients with intermediate uveitis.

Authors:  A M Klok; L Luyendijk; M J Zaal; A Rothova; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

2.  Elevated serum chemokine levels in Behçet's disease with uveitis.

Authors:  N Bozkurt; H Kazokoglu; S Yavuz; T Bavbek; H Direskeneli
Journal:  Rheumatol Int       Date:  2003-04-24       Impact factor: 2.631

3.  Systemic CD4(+) T cell phenotype and activation status in intermediate uveitis.

Authors:  C C Murphy; L Duncan; J V Forrester; A D Dick
Journal:  Br J Ophthalmol       Date:  2004-03       Impact factor: 4.638

Review 4.  The role of chemokines and their receptors in uveitis.

Authors:  Ahmed M Abu El-Asrar; Sofie Struyf; Ghislain Opdenakker; Karel Geboes; Jo Van Damme
Journal:  Int Ophthalmol       Date:  2007-03-13       Impact factor: 2.031

Review 5.  Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype?

Authors:  Kenneth G-J Ooi; Grazyna Galatowicz; Virginia L Calder; Susan L Lightman
Journal:  Clin Med Res       Date:  2006-12

6.  Adalimumab specifically induces CD3(+) CD4(+) CD25(high) Foxp3(+) CD127(-) T-regulatory cells and decreases vascular endothelial growth factor plasma levels in refractory immuno-mediated uveitis: a non-randomized pilot intervention study.

Authors:  S Calleja; M Cordero-Coma; E Rodriguez; M Llorente; M Franco; J G Ruiz de Morales
Journal:  Eye (Lond)       Date:  2012-01-06       Impact factor: 3.775

7.  Plasma and whole-blood chemokine levels in patients with Behcet's disease.

Authors:  Toshikatsu Kaburaki; Yujiro Fujino; Hidetoshi Kawashima; Guillermo Merino; Jiro Numaga; Jun Chen; Kouji Matsushima
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-04-23       Impact factor: 3.117

8.  Capacity of ocular infiltrating T helper type 1 cells of patients with non-infectious uveitis to produce chemokines.

Authors:  H Takase; S Sugita; C Taguchi; Y Imai; M Mochizuki
Journal:  Br J Ophthalmol       Date:  2006-02-07       Impact factor: 4.638

9.  Intraocular and serum cytokine profiles in patients with intermediate uveitis.

Authors:  Natasa Vidovic Valentincic; Jolanda D F de Groot-Mijnes; Aleksandra Kraut; Peter Korosec; Marko Hawlina; Aniki Rothova
Journal:  Mol Vis       Date:  2011-07-20       Impact factor: 2.367

Review 10.  Immunopathogenic Background of Pars Planitis.

Authors:  Joanna Przeździecka-Dołyk; Agnieszka Węgrzyn; Anna Turno-Kręcicka; Marta Misiuk-Hojło
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2015-10-05       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.